Production of β-Lactamase Inhibitors by Streptomyces Species

Antibiotics
Daniela de Araújo Viana MarquesAna Lúcia Figueiredo Porto

Abstract

β-Lactamase inhibitors have emerged as an effective alternative to reduce the effects of resistance against β-lactam antibiotics. The Streptomyces genus is known for being an exceptional natural source of antimicrobials and β-lactamase inhibitors such as clavulanic acid, which is largely applied in clinical practice. To protect against the increasing prevalence of multidrug-resistant bacterial strains, new antibiotics and β-lactamase inhibitors need to be discovered and developed. This review will cover an update about the main β-lactamase inhibitors producers belonging to the Streptomyces genus; advanced methods, such as genetic and metabolic engineering, to enhance inhibitor production compared with wild-type strains; and fermentation and purification processes. Moreover, clinical practice and commercial issues are discussed. The commitment of companies and governments to develop innovative strategies and methods to improve the access to new, efficient, and potentially cost-effective microbial products to combat the antimicrobial resistance is also highlighted.

References

Jun 1, 1976·The Journal of Antibiotics·A G BrownG N Rolinson
Oct 1, 1986·Applied and Environmental Microbiology·J RomeroJ F Martín
Jan 1, 1988·Clinical Microbiology Reviews·K Bush
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·I N SimpsonC H O'Callaghan
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Mar 1, 1996·Applied Microbiology and Biotechnology·A F Mayer, W D Deckwer
Aug 1, 1997·Natural Product Reports·K H BaggaleyC J Schofield
Aug 30, 2000·Nature·M L Cohen
Nov 10, 2001·Archives of Microbiology·M G WatveB D Bhole
Nov 5, 2002·Current Opinion in Chemical Biology·Craig A Townsend
Aug 9, 2003·Letters in Applied Microbiology·J C LeeC J Kim
Oct 24, 2003·Current Opinion in Microbiology·Steven J Projan
Nov 4, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K Bush
Nov 4, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A F Boggs, G H Miller
Mar 11, 2005·Nature Reviews. Microbiology·Sarah J CoulthurstGeorge P C Salmond
Jul 8, 2005·Applied Microbiology and Biotechnology·F R Schmidt
Jan 6, 2006·Applied Microbiology and Biotechnology·Juliana C TeodoroAlberto C Badino
Jun 1, 1945·Proceedings of the National Academy of Sciences of the United States of America·S A WaksmanA Schatz
Dec 13, 2006·Nature Biotechnology·Prabhavathi Fernandes
Oct 31, 1947·Science·J EhrlichP R Burkholder
Dec 25, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Akova
Apr 1, 2008·Journal of Bacteriology·Yasuo OhnishiSueharu Horinouchi
May 3, 2008·Biotechnology Advances·Parag S SaudagarRekha S Singhal
Jul 9, 2008·The Journal of Biological Chemistry·Irina BorodinaJens Nielsen
Jan 9, 2009·Bioscience, Biotechnology, and Biochemistry·Sae-Jin KimChan-Wha Kim
May 29, 2009·Applied Biochemistry and Biotechnology·D A VianaA L F Porto
Aug 29, 2009·Science·Michael A Fischbach, Christopher T Walsh
Dec 10, 2009·Antimicrobial Agents and Chemotherapy·Karen Bush, George A Jacoby
Jan 13, 2010·Molecular Plant-microbe Interactions : MPMI·Dawn R D BignellRosemary Loria
Jan 13, 2010·Clinical Microbiology Reviews·Sarah M Drawz, Robert A Bonomo
Mar 2, 2010·Nature Reviews. Microbiology·Heather K AllenJo Handelsman
Aug 17, 2010·Applied Microbiology and Biotechnology·Ju Yeon SongKye Joon Lee
Oct 1, 1945·Proceedings of the Society for Experimental Biology and Medicine·A BONDI, C C DIETZ
Oct 1, 1945·Proceedings of the Society for Experimental Biology and Medicine·J S GOTS
Jan 1, 1945·American Journal of Clinical Pathology·H H PLOUGH
Dec 1, 1945·Proceedings of the Society for Experimental Biology and Medicine·C P MILLER, M BOHNHOFF
Jan 1, 1945·Acta Pathologica Et Microbiologica Scandinavica·K R ERIKSEN

❮ Previous
Next ❯

Citations

Oct 6, 2018·MedChemComm·Kamaleddin H M E Tehrani, Nathaniel I Martin
Nov 30, 2018·Antibiotics·Howard Ramirez-Malule
Aug 1, 2019·Antibiotics·Yvonne Mast, Evi Stegmann
Jan 20, 2019·Antibiotics·David Gómez-RíosRigoberto Ríos-Estepa
Mar 19, 2021·EcoSal Plus·Nicholas WaglechnerGerard D Wright
Aug 25, 2021·International Microbiology : the Official Journal of the Spanish Society for Microbiology·Mervat Morsy Abbas Ahmed El-GendyAhmed Mohamed Ahmed El-Bondkly

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Mini Reviews in Medicinal Chemistry
Jiao ChenWenbing Yao
Journal of the American Veterinary Medical Association
Paul Bloom
© 2022 Meta ULC. All rights reserved